This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by WAINFELD, B. Articles by FANKHAUSER, A. Search for Related Content PubMed PubMed Citation Articles by WAINFELD, B. Articles by FANKHAUSER, A.

(Circulation. 1957;15:426.)
© 1957 American Heart Association, Inc.

---

Clinical Evaluation of a New Oral Nonmercurial Diuretic

BENJAMIN WAINFELD M.D.¹; JACOB J. YARVIS M.D.¹; ARTHUR FANKHAUSER M.D.¹

¹ From the Medical Clinic, Out-Patient Department, Kings County Hospital Center, Brooklyn, N.Y.

The oral administration of the organomercurial drugs in patients requiring prolonged management of congestive failure has been rather unsatisfactory because of occasional toxic signs and symptoms. With the development of the pyrimidinedione derivatives as diuretic agents and encouraging pharmacologic studies in animals, clinical trial is warranted. A group of 24 patients who had received injections of mercurial diuretics for at least 6 months prior to study were treated with this new diuretic. Results of this experience are described.